Volume 27, Issue 1 (Apr 2019)
JSSU 2019, 27(1): 1128-1140 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
salvand G, Nikbakht M, Shakerian S. The effect of 12 weeks of circuit resistance training course on some of the inflammatory factors in obese non-alcoholic fatty liver men
. JSSU 2019; 27 (1) :1128-1140
URL: http://jssu.ssu.ac.ir/article-1-4778-en.html
URL: http://jssu.ssu.ac.ir/article-1-4778-en.html
Abstract: (3522 Views)
Introdution: Non-alcoholic fatty liver disease (NFALD) is a disease associated with metabolic syndrome and lifestyle. The purpose of the present study was to investigate the effect of 12 weeks of circuit resistance training course on interleukin-17 (IL-17) levels, 70 kDa thermal shock protein (HSP70), insulin resistance and serum levels of alanine aminotransferase (ALT), as well as aspartate aminotransferase (AST).
Method: In this clinical trial study, 30 males with NFALD were selected through targeted sampling and were randomly assigned to one of two groups of practice and control intervention. The training program included 12 weeks of resistive training and 3 training sessions per week, which was performed as periodic circuit resistance training. Before eating breakfast, blood sampling was done one day before the start of training and 3 days after the last training session. For statistical analysis, paired t-test was used to compare intra-group data. Independent t-test was used for comparison between groups. Data were used via the SPSS v 22 software. The significance was defined as P≤0.05.
Results: After the training course, compared to the control group a significant decrease was observed in weight (P = 0.008), BMI (P = 0.006), body fat percentage (P <0.001), insulin resistance (P <0.001), HSP70 (P <0.001), IL-17 (P <0.001), serum levels of ALT (P <0.001) and AST (P <0.001) enzymes.
Conclusion: Regarding the results of this study, circuit resistance training has an effective role in improving the liver function in NFALD patients by reducing insulin resistance and levels of inflammatory cytokines, this method of resistance training can be useful in the treatment of these patients.
Method: In this clinical trial study, 30 males with NFALD were selected through targeted sampling and were randomly assigned to one of two groups of practice and control intervention. The training program included 12 weeks of resistive training and 3 training sessions per week, which was performed as periodic circuit resistance training. Before eating breakfast, blood sampling was done one day before the start of training and 3 days after the last training session. For statistical analysis, paired t-test was used to compare intra-group data. Independent t-test was used for comparison between groups. Data were used via the SPSS v 22 software. The significance was defined as P≤0.05.
Results: After the training course, compared to the control group a significant decrease was observed in weight (P = 0.008), BMI (P = 0.006), body fat percentage (P <0.001), insulin resistance (P <0.001), HSP70 (P <0.001), IL-17 (P <0.001), serum levels of ALT (P <0.001) and AST (P <0.001) enzymes.
Conclusion: Regarding the results of this study, circuit resistance training has an effective role in improving the liver function in NFALD patients by reducing insulin resistance and levels of inflammatory cytokines, this method of resistance training can be useful in the treatment of these patients.
Keywords: Non-alcoholic fatty liver disease, Circuit resistance training, Interleukin-17, Thermal shock protein 70 kDa, Insulin resistance
Type of Study: Original article |
Subject:
Exercise Physiology
Received: 2018/12/25 | Accepted: 2019/01/19 | Published: 2019/05/13
Received: 2018/12/25 | Accepted: 2019/01/19 | Published: 2019/05/13
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
